122 related articles for article (PubMed ID: 1868439)
1. Establishment and characterization of a mouse monoclonal anti-fucosylceramide antibody, PC47H.
Ishihara H; Hattori H
Cancer Res; 1991 Aug; 51(16):4182-6. PubMed ID: 1868439
[TBL] [Abstract][Full Text] [Related]
2. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
[TBL] [Abstract][Full Text] [Related]
3. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung.
Yamada H; Ishihara H; Kitagawa H; Kawabata Y; Itoyama S; Sugawara I
Cancer Res; 1992 Aug; 52(16):4408-12. PubMed ID: 1322788
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
5. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of u-FCC, an antigen of anti-fucosylceramide antibody found in urine, in patients with gastric and colorectal carcinoma.
Tanimizu T; Ishihara H; Hattori H; Hamada S; Hirayama R
Cancer; 1998 Aug; 83(4):660-5. PubMed ID: 9708928
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
Masuko T; Yagita H; Hashimoto Y
J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
[TBL] [Abstract][Full Text] [Related]
8. Human IgG3 monoclonal antibody directed to an unbranched repeating type 2 chain (Gal beta 1----4GlcNAc beta 1----3Gal beta 1----4GlcNAc beta 1----3Gal beta 1----R) which is highly expressed in colonic and hepatocellular carcinoma.
Miyake M; Kohno N; Nudelman ED; Hakomori S
Cancer Res; 1989 Oct; 49(20):5689-95. PubMed ID: 2551493
[TBL] [Abstract][Full Text] [Related]
9. Secretory epithelial cell marker on gastrointestinal tumors and in human secretions defined by a monoclonal antibody.
Dippold WG; Klingel R; Bernhard H; Dienes HP; Knuth A; Meyer zum Büschenfelde KH
Cancer Res; 1987 Apr; 47(8):2092-7. PubMed ID: 3828998
[TBL] [Abstract][Full Text] [Related]
10. A cytotoxic monoclonal antibody to colon adenocarcinoma.
Kaszubowski PA; Terasaki PI; Chia DS; Kukes GD; Hardiwidjaja SI; Cicciarelli JC
Cancer Res; 1984 Mar; 44(3):1194-9. PubMed ID: 6362858
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive fucosylceramide as a B-cell differentiation marker.
Nakamura H; Yamada H; Kitagawa H; Masunaga A; Itoyama S; Sugawara I
Immunol Lett; 1993 Aug; 37(2-3):119-22. PubMed ID: 8258455
[TBL] [Abstract][Full Text] [Related]
12. Production of oligosaccharide-binding monoclonal antibodies of diverse specificities by immunization with purified tumor-associated glycolipids inserted into liposomes with lipid A.
Brodin T; Thurin J; Strömberg N; Karlsson KA; Sjögren HO
Eur J Immunol; 1986 Aug; 16(8):951-6. PubMed ID: 3743633
[TBL] [Abstract][Full Text] [Related]
13. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
Liu H
Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
[TBL] [Abstract][Full Text] [Related]
14. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
15. Similarities in function between pancreatic tumor cells and macrophages and their inhibition by murine monoclonal antibodies.
Schorlemmer HU; Bosslet K; Kern HF; Sedlacek HH
Behring Inst Mitt; 1988 Apr; (82):240-64. PubMed ID: 3408453
[TBL] [Abstract][Full Text] [Related]
16. Anti-alpha-galactosyl antibodies recognizing epitopes terminating with alpha1,4-linked galactose: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies.
Duk M; Kusnierz-Alejska G; Korchagina EY; Bovin NV; Bochenek S; Lisowska E
Glycobiology; 2005 Feb; 15(2):109-18. PubMed ID: 15342552
[TBL] [Abstract][Full Text] [Related]
17. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
Prat M; Morra I; Bussolati G; Comoglio PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
[TBL] [Abstract][Full Text] [Related]
18. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an anti-A human monoclonal antibody from a blood group A lung cancer patient: evidence for the occurrence of autoimmune response to difucosylated type-2 chain A.
Inoue H; Hirohashi S; Shimosato Y; Enjoji M; Clausen H; Hakomori S
Eur J Immunol; 1989 Dec; 19(12):2197-203. PubMed ID: 2606138
[TBL] [Abstract][Full Text] [Related]
20. Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization.
Payne WJ; Coggin JH
J Natl Cancer Inst; 1985 Sep; 75(3):527-44. PubMed ID: 2411994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
